SILO PHARMA, INC. Inventory Write-down
SILO PHARMA, INC. (SILO) reported Inventory Write-down of $137.95 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:InventoryWriteDown · last filed 2022-03-28
- SILO PHARMA, INC. inventory write-down for the quarter ending 2020-12-31 was $118.07K.
- SILO PHARMA, INC. inventory write-down for fiscal 2020 was $137.95K.
| Period end | Inventory Write-down 3 month | Inventory Write-down 9 month | Inventory Write-down 12 month |
|---|---|---|---|
| 2020-12-31 | $118.07K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $137.95K 10-K · filed 2022-03-28 | |
| 2020-09-30 | $19.88K 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |